Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Khiron Life Sciences Corp.
  6. Financials
    KHRN   CA49374L3065

KHIRON LIFE SCIENCES CORP.

(KHRN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 11512456,551,0--
Entreprise Value (EV)1 11590,356,540,050,049,0
P/E ratio --2,94x--1,43x-2,85x-2,85x
Yield ------
Capitalization / Revenue 129x12,9x7,05x3,34x0,92x0,55x
EV / Revenue 129x9,42x7,05x2,62x0,91x0,53x
EV / EBITDA -7,06x-3,29x-2,02x-2,34x-6,63x11,7x
Price to Book ------
Nbr of stocks (in thousands) 75 043116 612150 717179 117--
Reference price (CAD) 1,531,060,380,290,290,29
Announcement Date 04/30/201905/01/202004/29/2021---
1 CAD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 0,899,588,0215,355,392,8
EBITDA1 -16,3-27,4-28,0-17,1-7,554,20
Operating profit (EBIT)1 -19,9-37,7-29,1-23,9-14,2-2,90
Operating Margin -2 231%-394%-363%-156%-25,6%-3,13%
Pre-Tax Profit (EBT)1 --36,4--27,7-18,3-7,80
Net income1 --36,4--22,2-10,1-1,40
Net margin --380%--145%-18,3%-1,51%
EPS2 --0,36--0,20-0,10-0,10
Dividend per Share ------
Announcement Date 04/30/201905/01/202004/29/2021---
1 CAD in Million
2 CAD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 1,932,522,843,004,205,30
EBITDA1 -4,71-5,80-4,02-3,70-3,40-3,00
Operating profit (EBIT) ------
Operating Margin ------
Pre-Tax Profit (EBT) ------
Net income ------
Net margin ------
EPS ------
Dividend per Share ------
Announcement Date 11/30/202004/29/202105/27/2021---
1 CAD in Million
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 -33,4-11,01,002,00
Leverage (Debt / EBITDA) -1,22x-0,64x0,13x-0,48x
Free Cash Flow1 -18,6-36,2--13,2-11,1-2,35
ROE (Net Profit / Equities) --76,1%--49,1%-33,5%-4,90%
Shareholders' equity1 -47,8-45,230,128,6
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 3,836,09-3,003,253,55
Capex / Sales 429%63,6%-19,6%5,88%3,83%
Announcement Date 04/30/201905/01/202004/29/2021---
1 CAD in Million
Key data
Capitalization (CAD) 51 048 364
Capitalization (USD) 40 575 438
Net sales (CAD) 8 017 000
Net sales (USD) 6 378 325
Free-Float 94,7%
Free-Float capitalization (CAD) 48 364 991
Free-Float capitalization (USD) 38 442 578
Avg. Exchange 20 sessions (CAD) 253 782
Avg. Exchange 20 sessions (USD) 201 909
Average Daily Capital Traded 0,50%
EPS & Dividend